Purpose: The coronavirus disease 2019 (COVID-19) pandemic is disrupting urology health-care worldwide. Reduced emergency room visits resulting in adverse outcomes have most recently been reported in pediatrics and cardiology. We aimed to compare patients with emergency room visits for pyelonephritis in 2019 (pre-COVID-19 era) and within the first wave of pandemic in 2020 (COVID-19 era) with regard to the number of visits and severe adverse disease outcomes. Methods: We performed a retrospective multicentre study comparing characteristics and outcomes of patients with pyelonephritis, excluding patients with hydronephrosis due to stone disease, in 10 urology departments in Germany during a 1-month time frame in March and April in each 2019 and 2020. Results: The number of emergency room visits for pyelonephritis in the COVID-19 era was lower (44 patients, 37.0%) than in the pre-COVID-19 era (76 patients, 63.0%), reduction rate: 42.1% (p = 0.003). Severe adverse disease outcome was more frequent in the COVID-19 era (9/44 patients, 20.5%) than in the pre-COVID-19 era (5/76 patients, 6.6%, p = 0.046). In detail, 7 versus 3 patients needed monitoring (15.9 vs. 3.9%), 2 versus no patients needed intensive-care treatment (4.5 vs. 0%), 2 versus no patients needed drain placement (4.5 vs. 0%), 2 versus no patients had a nephrectomy (4.5 vs. 0%), and 2 versus 1 patient died (4.5 vs. 1.3%). Conclusion: This report of collateral damage during CO-VID-19 showed that emergency room visits were decreased, and severe adverse disease outcomes were increased for patients with pyelonephritis in the COVID-19 era. Health authorities should set up information campaign programs actively encouraging patients to utilize emergency room services in case of severe symptoms specifically during the actual second wave of pandemic.

1.
Puliatti
S
,
Eissa
A
,
Eissa
R
,
Amato
M
,
Mazzone
E
,
Dell’Oglio
P
, et al.
COVID-19 and urology: a comprehensive review of the literature
.
BJU Int
.
2020
;
125
(
6
):
E7
14
. .
2.
Stensland
KD
,
Morgan
TM
,
Moinzadeh
A
,
Lee
CT
,
Briganti
A
,
Catto
JWF
, et al.
Considerations in the triage of urologic surgeries during the COVID-19 pandemic
.
Eur Urol
.
2020
;
77
(
6
):
663
6
.
3.
Gillessen
S
,
Powles
T
.
Advice regarding systemic therapy in patients with urological cancers during the COVID-19 pandemic
.
Eur Urol
.
2020
;
77
(
6
):
667
8
.
4.
Ribal
MJ
,
Cornford
P
,
Briganti
A
,
Knoll
T
,
Gravas
S
,
Babjuk
M
, et al.
European association of urology guidelines office rapid reaction group: an organisation-wide collaborative effort to adapt the european association of urology guidelines recommendations to the coronavirus disease 2019 era
.
Eur Urol
.
2020
;
78
(
1
):
21
28
.
5.
Kriegmair
MC
,
Kowalewski
KF
,
Lange
B
,
Heininger
A
,
Speck
T
,
Haas
H
, et al.
[Urology in the corona-virus pandemic: a guideline 4/20]
.
Urologe A
.
2020
;
59
(
4
):
442
9
. .
6.
Simonato
A
,
Giannarini
G
,
Abrate
A
,
Bartoletti
R
,
Crestani
A
,
De Nunzio
C
, et al.
Pathways for urology patients during the COVID-19 pandemic
.
Minerva Urol Nefrol
.
2020
;
72
(
3
):
376
83
.
7.
Motterle
G
,
Morlacco
A
,
Iafrate
M
,
Bianco
M
,
Federa
G
,
Xhafka
O
, et al.
The impact of COVID-19 pandemic on urological emergencies: a single-center experience
.
World J Urol
.
2020
:
1
5
. .
8.
Lazzerini
M
,
Barbi
E
,
Apicella
A
,
Marchetti
F
,
Cardinale
F
,
Trobia
G
.
Delayed access or provision of care in Italy resulting from fear of COVID-19
.
Lancet Child Adolesc Health
.
2020
;
4
(
5
):
e10
11
.
9.
Martin
GS
,
Mannino
DM
,
Eaton
S
,
Moss
M
.
The epidemiology of sepsis in the United States from 1979 through 2000
.
N Engl J Med
.
2003
;
348
(
16
):
1546
54
. .
10.
Porreca
A
,
Colicchia
M
,
D’Agostino
D
,
Amenta
M
,
Corsaro
A
,
Zaramella
S
, et al.
Urology in the time of coronavirus: reduced access to urgent and emergent urological care during the coronavirus disease 2019 outbreak in Italy
.
Urol Int
.
2020
;
104
(
7–8
):
631
6
. .
11.
Ahmed
K
,
Hayat
S
,
Dasgupta
P
.
Global challenges to urology practice during COVID-19 pandemic
.
BJU Int
.
2020
;
125
(
6
):
E5
6
.
12.
Desouky
E
.
BCG versus COVID-19: impact on urology
.
World J Urol
.
2020
:
1
5
. .
13.
Campi
R
,
Amparore
D
,
Capitanio
U
,
Checcucci
E
,
Salonia
A
,
Fiori
C
, et al.
Assessing the burden of nondeferrable major uro-oncologic surgery to guide prioritisation strategies during the COVID-19 pandemic: insights from three Italian high-volume referral centres
.
Eur Urol
.
2020
;
78
(
1
):
11
15
. .
14.
CJD
W
.
Risks from deferring treatment for genitourinary cancers: a collaborative review to Aid Triage and management during the COVID-19 pandemic
.
Eur Urol
.
2020
;
78
(
1
):
29
42
.
15.
Guo
H
,
Zhou
Y
,
Liu
X
,
Tan
J
.
The impact of the COVID-19 epidemic on the utilization of emergency dental services
.
J Dent Sci
.
2020
. .
16.
Tartari
F
,
Guglielmo
A
,
Fuligni
F
,
Pileri
A
.
Changes in emergency service access after spread of COVID19 across Italy
.
J Eur Acad Dermatol Venereol
.
2020
;
34
(
8
):
e350
e1
.
17.
Madanelo
M
,
Ferreira
C
,
Nunes-Carneiro
D
,
Pinto
A
,
Rocha
MA
,
Correia
J
, et al.
The impact of the COVID-19 pandemic on the utilization of emergency urological services
.
BJU Int
.
2020
;
126
(
2
):
256
8
. .
18.
Porreca
A
,
Colicchia
M
,
D’Agostino
D
,
Amenta
M
,
Corsaro
A
,
Zaramella
S
, et al.
Urology in the time of coronavirus: reduced access to urgent and emergent urological care during the coronavirus disease 2019 outbreak in Italy
.
Urol Int
.
2020
;
104
(
7–8
):
631
6
.
19.
Metzler
B
,
Siostrzonek
P
,
Binder
RK
,
Bauer
A
,
Reinstadler
SJ
.
Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage
.
Eur Heart J
.
2020
;
41
(
19
):
1852
3
.
20.
Connor
MJ
,
Winkler
M
,
Miah
S
.
COVID-19 pandemic: is virtual urology clinic the answer to keeping the cancer pathway moving?
BJU Int
.
2020
;
125
(
6
):
E3
4
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.